My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

ARK Genomic Revolution ETF (NY:ARKG)

29.67 -0.51 (-1.69%)

Official Closing Price Updated: 8:00 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ARK Genomic Revolution ETF

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

5 Cathie Wood Stocks to Buy in June ↗

June 09, 2022

These are the five best Cathie Wood stocks to buy in June. EXAS, IONS, KTOS, TRMB, and PATH can make excellent investments.

Via InvestorPlace

Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker ↗

June 09, 2022

Cathie Wood led Ark Invest on Wednesday initiated a position in Moderna Inc (NASDAQ: MRNA) after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide strong

Via Benzinga

Cathie Wood Is Selling Gene Editing Stocks. Here’s Why. ↗

June 02, 2022

Cathie Wood has recently sold off large positions in several gene-editing stocks from her ARKG ETF. What's behind Wood's latest moves?

Via InvestorPlace

Know The 2 Healthcare Companies Cathie Wood's Ark Invest Bought On Friday ↗

April 02, 2022

Cathie Wood's Ark Invest may have had a disappointing 2021, but the fund's purchases/liquidations are always watched keenly by investors. On Friday, ETFs managed by...

Via Benzinga

Tesla Bull Cathie Wood Bought $1M Shares In This Biotech Stock Today ↗

March 24, 2022

Tesla Inc (NASDAQ: TSLA) bull Cathie Wood led Ark Investment Management on Thursday further raised its exposure in China-based biotech company Burning Rock Biotech Ltd (NASDAQ: BNR).

Via Benzinga

A Leaky ARKK ↗

January 04, 2022

In a year when everything skyrocketed to nauseating highs, Cathie’s momentum-obsessed investing style was a dud.

Via Talk Markets

Neck Cream Reversal ↗

November 18, 2021

Cathie Wood's ARKG is down about 50% over the past 9 months.

Via Talk Markets

4 Big Ark Innovation Components Report Earnings This Week: Could It Spell More Danger For Cathie Wood? ↗

February 23, 2022

The Ark Funds ETFs have been hit hard in 2022 with growth stocks among the laggards as investors turned to value stocks. Many stockholders have begun to question ...

Via Benzinga

Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind' ↗

February 14, 2022

The psychedelics sector received its latest sign of acceptance from Wall Street with famed investor Cathie Wood taking a position ...

Via Benzinga

Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds ↗

February 09, 2022

There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of...

Via Benzinga

Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings ↗

February 05, 2022

Big pharma reporting season was muted, with the quarterly results and guidance coming in mixed.

Via Benzinga

Ark Funds Launching New Fund That Could Invest In Private Companies ↗

February 04, 2022

One of the biggest and most well-known ETF companies is launching a new closed-end fund that provides major differences from its existing ETFs.

Via Talk Markets

Ark Funds Launching New Fund That Could Invest In Private Companies ↗

February 04, 2022

One of the biggest and most well-known ETF companies is launching a new closed-end fund that provides major differences from its existing ETFs....

Via Benzinga

Small Cap Biotech Stocks: Is it time to start trading? ↗

January 31, 2022

It’s time to trade beaten-up small cap biotech stocks.

Via Talk Markets

Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years? ↗

January 14, 2022

One of the best-known and well-covered ETF companies over the past five years has been ARK Invest, led by Cathie Wood. With t...

Via Benzinga

UiPath Stock Is Worth Believing in Here as Wood Holds Fast ↗

December 30, 2021

Cathie Woods ARK Investment ETFs have loaded up on shares of UiPath despite the decline. PATH stock has plenty of upside from here.

Via InvestorPlace

Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot ↗

December 22, 2021

The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.

Via Talk Markets

Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday ↗

December 20, 2021

Cathie Wood’s Ark Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc (NASDAQ: QSI). Shares of the medical...

Via Benzinga

Biotech Playbook 2021: No Help From Small Caps In Q4 ↗

December 14, 2021

Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...

Via Talk Markets

Bionano Genomics Proves Not Everything Genetic is Gold ↗

December 01, 2021

Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.

Via InvestorPlace

Cathie Wood Testing 'ARK On Steroids' As ARK Funds Struggle ↗

November 24, 2021

Wood said ARK is testing a strategy to short stocks in the big benchmark indexes,

Via Investor's Business Daily

Topics Electric Vehicles

Don't Look Now, But Cathie Wood's Ark Is Taking On Water ↗

November 24, 2021

Among the biggest losers over the last 48 hour tech stock volatility has been...well, everything in Cathie Wood's

Via Talk Markets

Biotech Stocks are Due for a Rally ↗

November 22, 2021

There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.

Via Talk Markets

Yes, Cathie Wood's $700,000 Bitcoin Price Prediction Is Legit ↗

November 21, 2021

A Bitcoin price prediction of $700,000 - more than 10 times the recent price - would strike most people as delusional. But this eye-popping target doesn't come from a Bitcoin fan. It comes from Wall...

Via Talk Markets

Tesla (TSLA) Not Enough To Lift ARK Innovation (ARKK) ↗

October 27, 2021

An updated look at Cathie Wood’s ARK ETFs relative strength versus the S&P 500 SPY ETF.

Via Talk Markets

Topics Stocks

ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM ↗

October 21, 2021

The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage.

Via Talk Markets

Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam' ↗

October 06, 2021

Shares of synthetic biology company Ginkgo Bioworks Holdings Inc (NYSE:

Via Benzinga

Mike Khouw Sees Unusual Options Activity In ARK Genomic Revolution ETF ↗

September 29, 2021

On CNBC's "Options Action," Mike Khouw said ARK Genomic Revolution ETF (BATS: ARKG) was active on Tuesday as it traded six times its average daily put volume....

Via Benzinga

Biotech Playbook Revisited As Technicals Weaken ↗

September 27, 2021

Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still...

Via Talk Markets

Look For The Q4 Biotech Bounce In Mid-Small Caps ↗

September 17, 2021

Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best...

Via Talk Markets

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.